Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01916447
Title A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Taiho Oncology, Inc.
Indications

gastrointestinal system cancer

Therapies

Bevacizumab

Trifluridine-tipiracil hydrochloride

Irinotecan

Age Groups: adult
Covered Countries USA


No variant requirements are available.